This week the US Food and Drug Administration approved the release of fingolimod (trade name Gilenya®), the first oral medication for the treatment of remitting relapsing multiple sclerosis. Swedish Neuroscience Institute is proud to have participated in the pivotal clinical trial that led to the approval of Gilenya. Gilenya is a welcome addition to the set of medications available to patients living with MS. There are currently five injectable therapies and two intravenous therapies approved by the FDA for the treatment of MS. Although these treatments are very effective, many patients have been hoping for an oral alternative. Some patients are finding that they have “injection fatigue” or are running out of places to inject the medication. It is important to note, however, that not all patients should switch to Gilenya. Patients with stable disease should remain on their medications. Patients need to be informed of the risks associated with Gilenya, including slowed heart rate, increased blood pressure, difficulty breathing, abnormal liver function, and infection, and how these risks may apply to them. If you are wondering whether Gilenya is right for you, please ask your neurologist.
Recommended for you
What is a meningioma?
These tumors account for 30% of all brain and spinal cord tumors. Learn more from a Providence Swedish neurosurgeon.
Watch this video of recent online event and hear from experts and patients about how this advanced technology is changing lives.
Improve your health, improve your brain
A new report shows healthy habits improve your brain health and reduce your risk of dementia by up to 40%. A neuropsychologist shares what you should know. Watch this short video.
Providence Swedish earns national recognitions from the American Heart Association
Dedication to best practices in life-saving stroke and diabetes care garners multiple Get With The Guidelines awards.
Learn BE FAST, because every second counts during a stroke
Watch video: Learn this simple method for recognizing stroke symptoms. It may help you save a life.
Time is brain: new technology is a game-changer for patients with seizures
Swedish is the only hospital in the Puget Sound region using Ceribell, a portable device that helps speed diagnosis and treatment during neurological emergencies. Learn more.
New Parkinson’s disease test can help refine treatments and support more efficient research
Swedish is part of a trial that has shown significant promise for the early diagnosis of Parkinson’s.
With Swedish’s telehealth services, multiple sclerosis patients have more options for care
Virtual visits bring advanced care to more communities and relieve the strain and cost of traveling for many patients with MS.
Essential tremor ran in this family. Swedish neuroscience experts used focused ultrasound to treat the condition, which has plagued them for decades. Learn more.
Empathy, love and compassion are essential for patients with chronic pain and those who care for them
Providence Swedish experts share some advice for building supportive relationships between patients, caregivers and loved ones.
Swedish is the first Washington State hospital to offer groundbreaking ALS treatment
Tofersen, a new drug, is the first gene therapy for a familial form of amyotrophic lateral sclerosis.
What is Guillain-Barré Syndrome?
A Swedish expert discusses the autoimmune disease and its diagnosis and treatment.
Watch video: Balance is the key to meeting life's demands in a healthy way
A Swedish behavioral health expert offers guidance for finding our way back to center when life feels overwhelming.
Swedish is a destination for innovative, world-class care
Seattle’s KING 5 TV hosted a panel of sought-after Swedish specialists for a conversation about advanced treatments at Swedish and why patients from around the world choose us for their care.
Focused ultrasounds treat tremors, restoring patients' quality of life
A Swedish patient shares his experience of the procedure's life-changing success.
Understanding aphasia
A Swedish expert explains aphasia, a disorder that affects the area of your brain that controls language and communication.
Watch videos: Learn how Swedish's MS Center Adventure Program fosters joy and community
Occupational Therapist Simon Gale, the program's leader, on New Day Northwest. Share the thrill of skydiving with a program participant.
Parkinson's Foundation designates Swedish's Movement Disorders Program as a Comprehensive Care Center
The Parkinson’s Foundation Comprehensive Care Center designation recognizes leadership in providing high-quality care for patients with Parkinson’s disease.
The FDA has approved a game-changing drug for Alzheimer's disease. What should you know?
Nancy Isenberg, M.D., medical director of Swedish’s Center for Healthy Aging, weighs in.
Providence Swedish joined a host of community partners on June 21 for a Brain Health Block Party to raise awareness about the importance of brain health.